BRM/Biomere Announces the Appointment of a Senior Vice President of Science and Business Development
Biomedical Research Models Inc./Biomere, a privately held preclinical contract research organization (CRO) which specializes in life-threatening diseases such as autoimmune, multiple sclerosis, diabetes and virology, announced today the appointment of Dr. Alain Stricker-Krongrad Ph.D. as Senior Vice President of Science and Business Development. In his new position, Dr. Stricker-Krongrad will be overseeing scientific governmental and contractual preclinical research and guide BRM/Biomere during the national expansion phase of its business.
"Biomedical Research Models/Biomere is very fortunate to have attracted a true leader in preclinical outsourcing and development fields to guide Biomedical Research Models/Biomere ambitious research efforts. We welcome Dr. Stricker-Krongrad in joining our team," said President, Dennis Guberski.
Dr. Stricker-Krongrad joins Biomedical Research Models Inc. with over 20 years of experience in pharmacology and preclinical research. Since 2008 he served as Chief Scientific Officer of Charles River Laboratories (CRL) and helped advance key science-based programs and helped foster science-related initiatives and capabilities. From 2006 to 2008 Dr. Stricker-Krongrad was the director and head of preclinical safety and pharmacology at CRL, Preclinical Services. During his tenure he developed short- and long-term strategic plans for new technologies and services and was in charge of the non-clinical evaluation (efficacy and safety) of synthetics, biologics, cell-based products, devices and surgical products. Dr. Stricker-Krongrad also held managerial positions at Millennium Pharmaceuticals and Athersys, in the U.S. and Novartis Headquarters in Switzerland. Dr. Stricker-Krongrad obtained his Ph. D in Pharmacology at the University of Henri Poincare (France), his Post-Doctoral training at INSERM, where he received two international awards for his research and conducted his Post-Graduate training in Clinical Pharmacology, Drug Development and Regulation at Tufts University. Dr. Stricker-Krongrad has published more than 60 peer-reviewed papers and is a member of the Editorial Board of Expert Opinion in Drug Discovery.
“I am very pleased to join BRM/Biomere and I do look forward to guiding and fostering the scientific development of this wonderful organization in a fast-growing outsourcing environment” said Dr. Stricker-Krongrad.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.